Read the clinical evidence on Reconval and learn why Reconval works so well

Anti-EGFR-Therapie

Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors

Ralf-Dieter Hofheinz, Siegfried Segaert, María José Safont, Gaston Demontyd, Hans
Critical Reviews in Oncology/Hematology 114 (2017) 102–113

Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: A post hoc analysis of the EVITA trial

M.R. Gaiser, S. Lorenzen, K. Merx, J. Trojan, J. Ocvirk, T.J. Ettrich, S.-E. Al- Batran, H. Schulz, N. Homann, H.-P. Feustel, M. Schatz, M. Kripp, N. Schulte, S. Heeger, S. Vlassak, W. Koch, R.-D.. Hofheinz

Radiotherapy

Radiotherapy treatment can affect your skin making it go red or darker

Radiotherapy and your skin | Cancer in general | Cancer Research UK

Pharmazeutische Zeitung online: Strahlentherapie: Pharmazeutische Betreuung bei Hautveränderungen

Chemotherapy

CONTINUING MEDICAL EDUCATION

Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer Part I. Conventional chemotherapeutic drugs
Claire Marie Reyes-Habito, MD,a and Ellen K. Roh, MDb Laguna, Philippines, and Boston, Massachusetts

Literature for Reconval and interferon beta therapy

Vitamin K cream reduces reactions at theinjection site in patients with relapsing–remitting multiple sclerosis treated with subcutaneous interferon beta – VIKING study

Roberta Lanzillo, Multiple Sclerosis Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Via Pansini 5, Napoli, 80131, Italy.

Multiple Sclerosis Journal, 1–2, DOI: 10.1177/1352458514562989
© The Author(s), 2015.
Reprints and permissions:
www.sagepub.co.uk
journalsPermissions.nav

Multiple Sclerosis: Symptoms and side effects management

Int J MS Care 2006; 8 (Supplement 1).

Bayas A and Rieckmann P. Managing the adverse effects of interferon-beta therapy in multiple sclerosis

Drug Saf 2000; 22: 149–159.

Press

UK launch for Medicis Health's Reconval creams - PharmaTimes

https://academic.oup.com/annonc/article/29/4/796/4939482

EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity - Annals of Oncology, Volume 29, Issue 4